biotech · NSCLC Stage IV · Poliomyelitis
BioMarin Pharmaceutical
Biotech Pharmaceutical Co.,
Biotech Pharmaceutical Co is a biotech organization headquartered in CN. Primary therapeutic focus areas include NSCLC Stage IV, Poliomyelitis, Hyperlipidemias, Non-Hodgkin Lymphoma, Hepatocellular Carcinoma (HCC). NovaP
770 Lindaro Street, San Rafael, CA 94901, US HQ
1997 Founded
3,171 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 770 Lindaro Street, San Rafael, CA 94901, US
- Founded
- 1997
- Employees
- 3,171
- Programs
- 40
- Drugs
- 37
- Patents
- 0
Recombinant Human VEGF Receptor-Fc Fusion Protein
Phase 3 · mab · Neovascular Age-related Macular Degeneration
Recombinant Human VEGF Receptor-Fc Fusion Protein for Neovascular Age-related Macular Degeneration is a Phase 3 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code KHSWKH902005
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Biotech Pharmaceutical Co.,
- Phase
- Phase 3
- Modality
- mab
- Indication
- Neovascular Age-related Macular Degeneration
- Status
- completed
- Trials
- 1